Jupiter Neurosciences Income Statement (2024-2025) | JUNS

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) -0.03M-0.06M-0.11M0.02M-0.00M-0.00M-0.00M-0.06M
Operating items
Research & Development (Quarter) 0.10M0.10M0.09M0.20M0.47M0.76M0.82M0.04M
Selling, General & Administrative (Quarter) 0.47M0.46M0.40M1.26M1.07M1.51M1.48M2.78M
Operating Expenses (Quarter) 0.57M0.56M0.49M1.46M1.54M2.26M2.30M2.83M
Operating Income (Quarter) -0.57M-0.56M-0.49M-1.46M-1.54M-2.26M-2.30M-2.81M
EBIT (Quarter) -0.57M-0.56M-0.49M-1.46M-1.54M-2.26M-2.30M-2.81M
Non-operating items
Non Operating Investment Income (Quarter) -0.04M-0.03M0.01M
Interest & Investment Income (Quarter) 62.0053.0023.000.01M0.01M0.01M0.01M
Other Non Operating Income (Quarter) -0.09M
Non Operating Income (Quarter) -0.06M0.87M-0.10M-0.07M0.01M0.01M0.01M0.23M
Net income details
EBT (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Profit After Tax (Quarter) -0.63M0.31M-0.59M-1.53M-1.53M-2.25M-2.29M-2.58M
Income from Continuing Operations (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Consolidated Net Income (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Income towards Parent Company (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Net Income towards Common Stockholders (Quarter) -0.64M-0.61M-0.60M-1.48M-1.53M-2.25M-2.29M-2.87M
Additional items
EPS (Basic) (Quarter) -0.020.01-0.02-0.05-0.05-0.07-0.07-0.07
EPS (Weighted Average and Diluted) (Quarter) -0.020.01-0.02-0.05-0.05-0.07-0.07-0.07
Shares Outstanding (Weighted Average) (Quarter) 26.53M27.54M27.83M28.78M33.10M33.39M34.04M34.63M
Shares Outstanding (Diluted Average) (Quarter) 26.53M30.59M27.83M28.78M33.10M33.18M33.45M34.63M
EBITDA (Quarter) -0.57M-0.56M-0.49M-1.46M-1.54M-2.26M-2.30M-2.81M
Interest Expenses (Quarter) 0.07M0.06M0.11M0.03M0.00M0.00M0.00M0.06M